- Home
- MBOT vs PFO Comparison
MBOT vs PFO Comparison
Compare MBOT & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBOT | PFO |
|---|---|---|
| Founded | 2010 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.7M | 123.3M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | MBOT | PFO |
|---|---|---|
| Price | $2.55 | $9.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 34.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | ★ 30.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $116,887.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4,200.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.35 | $8.01 |
| 52 Week High | $4.62 | $9.90 |
Technical Indicators
Market Signals| Indicator | MBOT | PFO |
|---|---|---|
| Relative Strength Index (RSI) | 62.28 | 21.91 |
| Support Level | $2.34 | $9.17 |
| Resistance Level | $2.64 | $9.76 |
| Average True Range (ATR) | 0.16 | 0.10 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 77.86 | 7.89 |
Price Performance
Historical ComparisonAbout MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.